Informing HPV vaccine pricing for government-funded vaccination in mainland China: a modelling study.

ABSTRACT:

Background

The high price of HPV vaccines remains a significant barrier to vaccine accessibility in China, hindering the country's efforts toward cervical cancer elimination and exacerbating health inequity. We aimed to inform HPV vaccine price negotiations by identifying threshold prices that ensure that a government-funded HPV vaccination programme is cost-effective or cost-saving.

Methods

We used a previously validated transmission model to estimate the health and economic impact of HPV vaccination over a 100-year time horizon from a healthcare payer perspective. Threshold analysis was conducted considering different settings (national, rural, and urban), cervical cancer screening scenarios (cytology-based or HPV DNA-based, with different paces of scale-up), vaccine types

SUBMITTER: You T 

PROVIDER: S-EPMC11489076 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature